# NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals

> Contract award record from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Contract winner: Mercury Pharmaceuticals Limited
- Award value: £304,504,000
- Tender value: £304,504,000
- Award date: 24 April 2023
- Published: 6 April 2023
- Contract start: 1 May 2023
- Contract end: 30 April 2025
- Stage: awarded
- Procurement category: goods
- Notice ID: 4df14586-94d9-4b98-adbf-f5a321e30282-633180
- OCID: ocds-b5fd17-f3419ee6-884e-4ba4-9f88-cdfcb350ba4e

## Description

NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals Offer reference number: CM/PHR/22/5675 CM/PHR/22/5675/01 - NHS Framework Agreement for Branded Medicines - National Category Tender Lot 1\. Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 24 months CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines - National Tender Lot 2\. Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 24 months

## Related contract awards

- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England
- [Provision of national e-portfolio 26/27](/contracts/ocds-b5fd17-7e027849-39ea-4eb8-8eb0-3b38f18dcca4): NHS England
- [D&A Platform Run & Maintain](/contracts/ocds-b5fd17-58fe109d-49a3-4eea-957d-31f6bd69ff81): NHS England
- [NHS National Generic Pharmaceuticals - Lenalidomide](/contracts/ocds-b5fd17-217bd3c1-6e85-44b0-8f07-cd2ff7d988b7): NHS England
- [NHS National Pharmaceuticals Transition 2021\_3](/contracts/ocds-b5fd17-d87b195f-23f2-4420-b141-6d1b0d6ffb05): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/4df14586-94d9-4b98-adbf-f5a321e30282-633180)